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Abstract 
Review on MIR143, with data on DNA/RNA and 
where the gene is implicated. 
Identity 
Other names: MIRN143 
HGNC (Hugo): MIR143 
Location: 5q32 
Local order: According to RefSeq, hsa-miR-143 is 
clustered together with hsa-miR-145, and this 
microRNA-143/145 cluster is located in the non-
protein coding MIR143 host gene (MIR143HG). 
Genes flanking hsa-miR-143 are: PCYOX1L 
(prenylcysteine oxidase 1 like; + strand), IL17B 
(interleukin 17B; - strand), MIR143 host gene (+ 
strand), CSNK1A1 (casein kinase 1 alpha 1; - 
strand), and RPL29P14 (ribosomal protein L29 
pseudogene 14; - strand). 
DNA/RNA 
Description 
hsa-miR-143 is clustered with miR-145, which are 
separated by approximately 1.6 kb, and are located 
within an intergenic region on chromosome 5 
(5q32). Positions of the clustered miRNAs are: 
- hsa-mir-143: chr5: 148808481-148808586 [+] 
- hsa-mir-145: chr5: 148810209-148810296 [+]. 
Transcription 
The miR-143/145 cluster was demonstrated to be 
transcribed from a non-protein coding host gene 
(MIR143HG; GenBank: NR_027180) into an 11 kb 
primary miRNA transcript (pri-miRNA), which was 
then processed into the mature microRNAs (Iio et 
al., 2010). Expression of the cluster host gene and 
mature miR-143 were found to be reduced in 
various human cancer tissues and cell lines (Iio et 
al., 2010).  
 
Genes flanking hsa-miR-143 on chromosome 5q32. The red arrow indicates the position and orientation of miR-143. 
 
 
 
The stem-loop structure of hsa-miR-143, with sequences of mature miR-143-5p and miR-143-3p highlighted in red. 
 
MIR143 (MicroRNA 143) Kwong A, et al. 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2014; 18(10) 725 
DEAD-box RNA helicase 6 (DDX6) was reported 
to post-transcriptionally down-regulate miR-
143/145 levels by increasing the instability of 
MIR143 host gene RNA product (Iio et al., 2013). 
Moreover, tumour suppressor protein p53 was 
reported to enhance the miR-143 maturation in a 
transcription-independent manner (Suzuki et al., 
2009). 
Pre-mir-143: 
- Accession no.: MI0000459 
- Length: 106 nt 
- Sequence:  
GCGCAGCGCCCUGUCUCCCAGCCUGAGGU
GCAGUGCUGCAUCUCUGGUCAGUUGGGAG
UCUGAGAUGAAGCACUGUAGCUCAGGAAG
AGAGAAGUUGUUCUGCAGC 
Mature hsa-miR-143-5p:  
- Accession no.: MIMAT0004599 
- Length: 22 nt 
- Sequence:  
27- GGUGCAGUGCUGCAUCUCUGGU -48 
Mature hsa-miR-143-3p:  
- Accession no.: MIMAT0000435 
- Length: 21 nt 
- Sequence: 
 61- UGAGAUGAAGCACUGUAGCUC -81 
Pseudogene 
No pseudogenes were reported for miR-143. 
Protein 
Note 
miRNAs are not translated into amino acids. 
Mutations 
Note 
No mutations have been reported within the 
precursor or mature miR143 sequences.  
However, several single nucleotide variations 
(SNVs), including rs41291957, rs4705343, 
rs353292, rs353293, rs17796757, rs4705341, 
rs3733845, rs3733846, rs353286 and rs17796714, 
have been reported within the MIR143 host gene 
sequence, upstream of the miR-143/145 cluster. 
Implicated in 
Non-small cell lung cancer 
Note 
miR-143 has been found to be down-regulated in 
non-small cell lung cancer (NSCLC) tissues and 
was negatively correlated with PKCε expression.  
It was shown to regulate PKCε expression and was 
associated with apoptosis in NSCLC cells (Zhang et 
al., 2013b). 
 
Colorectal cancer 
Note 
miR-143 level was found to be down-regulated in 
colorectal cancer patients' blood and tumour tissues. 
Over-expression of miR-143 inhibited tumour 
growth and angiogenesis, and increased the 
chemosensitivity to oxaliplatin treatment (Qian et 
al., 2013).  
miR-143 was also reported to reduce the invasion 
and migration of colorectal carcinoma cells by 
targeting the Toll-like receptor 2 (TLR2) signalling 
pathway (Guo et al., 2013). 
Pancreatic cancer 
Note 
miR-143 was reported to modulate the 
prostaglandin E2 (PGE2) production and PGE2-
mediated cellular proliferation, in pancreatic cancer 
cells, by targeting the COX-2 mRNA stability and 
expression (Pham et al., 2013). 
Esophageal squamous cell 
carcinoma 
Note 
miR-143 expression was reduced in esophageal 
squamous cell carcinoma (ESCC) tissues as 
compared with the adjacent normal tissues. 
Restoration of the miR-143 expression was 
demonstrated to induce ESCC cells apoptosis and 
suppress the cell migration and invasion (Ni et al., 
2013). 
Prostate cancer cells 
Note 
miR-143 and miR-145 were reported to inhibit the 
cell viability and tumorigenicity of the bone 
metastatic prostate cancer cells, PC-3.  
They were suggested to play an important role in 
the bone metastasis of prostate cancer by regulating 
the cancer stem cell characteristics (Huang et al., 
2012). 
Cervical cancer 
Note 
miR-143 level was deregulated in cervical cancer 
tissues, as demonstrated by miRNA microarray 
(Liu et al., 2012).  
Over-expression of miR-143 in HeLa cells was 
reported to promote apoptosis and suppress 
xenograft tumour formation, by targeting the Bcl-2 
gene. 
Bladder cancer cells 
Note 
miR-143 and miR-145 co-treatment on bladder 
cancer cell lines, T24 and NKB1, was showed to  
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synergistically inhibit cell growth by suppressing 
the PI3K/Akt and MAPK signalling pathways 
(Noguchi et al., 2013). 
Liposarcoma 
Note 
miR-143 expression was found to be reduced in 
both well-differentiated (WDLS) and 
dedifferentiated liposarcomas (DDLS). Re-
expression of miR-143 inhibited DDLS cell 
proliferation, induced apoptosis, and suppressed the 
expression of a module of genes including Bcl-2, 
topoisomerase 2A (TOP2A), polo-like kinase 
1(PLK1), and protein regulator of cytokinesis 1 
(PRC1) (Ugras et al., 2011). 
Breast cancer 
Note 
Reduced levels of miR-143 was demonstrated in 
different breast cancer cell lines and primary 
tumours. Restoration of the miR-143 expression in 
breast cancer cells was found to inhibit cell 
proliferation and the formation of soft agar 
colonies. DNA methyltransferase 3A (DNMT3A) 
was validated as a direct target of miR-143, which 
resulted in the regulation of phosphatase and tensin 
homolog (PTEN) and TNFRSF10C promoter 
methylation (Ng et al., 2013). 
Ulcerative oesophagitis 
Note 
Up-regulation of miR-143 expression was reported 
in the oesophageal mucosa of ulcerative 
oesophagitis patients. It was suggested to induce 
apoptosis, and regulate the cell proliferation of 
oesophageal epithelium in response to gastro-
oesophageal reflux (Smith et al., 2013). 
Glucose Metabolism 
Note 
miR-143 was reported to inhibit glycolysis in a 
variety of cancer cells, including breast cancer, 
glioblastoma, colon cancer, head and neck 
squamous cell carcinoma, and lung cancer (Fang et 
al., 2012; Gregersen et al., 2012; Jiang et al., 2012; 
Peschiaroli et al., 2013; Zhao et al., 2013). 
Hexokinase 2 (HK2) was validated as a direct target 
of miR-143, in which their interaction was 
hypothesized to be an important regulator of 
glucose metabolism in cancer cells. 
MDM2-p53 pathway 
Note 
miR-143 and miR-145 were reported to negatively 
modulate MDM2 expression and were post-
transcriptionally activated by tumour suppressor 
protein p53. Together, miR-143/145, MDM2 and 
p53 form a regulatory feedback loop that was 
shown to modulate cell proliferation and apoptosis 
in the head and neck squamous cell carcinomas 
(Zhang et al., 2013a). 
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